Skip to content
Yog Pharma
Central nervous systemSerotonin-norepinephrine reuptake inhibitor (SNRI)

Duloxetine Hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI) indicated for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia and chronic musculoskeletal pain. We supply it to US manufacturers of delayed-release capsules.

CAS136434-34-9333.9 g/molC18H20ClNOS
2D structure of Duloxetine Hydrochloride, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 60834) and FDA’s substance registry

CAS number

136434-34-9

Molecular formula

C18H20ClNOS

Molecular weight

333.9g/mol

FDA UNII

IUPAC name

(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine;hydrochloride

InChIKey

BFFSMCNJSOPUAY-LMOVPXPDSA-N

Appearance
White to slightly brownish-white solid.
Solubility
Slightly soluble in water.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

A secondary amine. N-nitroso-duloxetine led to US capsule recalls in 2024, so ask for confirmatory testing on the API and not only a paper assessment. It also degrades in acid, which is why finished products are enteric-coated.

On the US market

Reference product
CymbaltaNDA 021427
Approved ANDAs
16 with a marketed product
Approved forms and strengths
  • Delayed-release capsule (pellets) 20 mg to 120 mg, in 7 strengths

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com